2-Oxoglutarate Analog-Based Biomolecular Tools for Exploring Structure-Activity Relationships in Nonheme Iron Enzymes

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• 2-oxoglutarate (2OG)-dependent nonheme iron (NHFe) enzymes hydroxylate C(sp3)-H bonds, playing key roles in cellular processes.
• Therapeutic targeting of these enzymes is difficult due to conserved active sites.

Purpose of the Study:

• To design and investigate 2OG analogs as tools to probe the active site of prolyl hydroxylase domain 2 (PHD2).
• To establish structure-activity relationships for developing novel PHD2 inhibitors.

Main Methods:

• Rational design of 2OG analogs.
• Enzyme activity assays and steady-state kinetics.
• Immunoblot studies for intracellular activity.
• Computational modeling and mutagenesis studies.

Main Results:

• A new class of aryl-conjugated 2OG analogs demonstrated varied inhibition (up to 12-fold) by competing with 2OG for the PHD2 active site.
• Analogs were found to be biologically active and capable of intracellular PHD2 targeting.
• Computational and mutagenesis studies revealed a unique 'flipped' binding conformation of the analogs, highlighting key interactions for inhibition.

Conclusions:

• The developed 2OG analogs serve as valuable tools for understanding PHD2 active site interactions.
• These findings provide a foundation for designing potent and selective PHD2 inhibitors for therapeutic applications.